Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e545-53. doi: 10.1016/j.ijrobp.2011.06.1958. Epub 2011 Oct 17.
Intrafraction rotation of more than 45° and 25° has been observed for lung and prostate tumors, respectively. Such rotation is not routinely adapted to during current radiotherapy, which may compromise tumor dose coverage. The aim of the study was to investigate the geometric and dosimetric performance of an electromagnetically guided real-time dynamic multileaf collimator (DMLC) tracking system to adapt to intrafractional tumor rotation.
MATERIALS/METHODS: Target rotation was provided by changing the treatment couch angle. The target rotation was measured by a research Calypso system integrated with a real-time DMLC tracking system employed on a Varian linac. The geometric beam-target rotational alignment difference was measured using electronic portal images. The dosimetric accuracy was quantified using a two-dimensional ion chamber array. For each beam, the following five delivery modes were tested: 1) nonrotated target (reference); 2) fixed rotated target with tracking; 3) fixed rotated target without tracking; 4) actively rotating target with tracking; and 5) actively rotating target without tracking. Dosimetric performance of the latter four modes was measured and compared to the reference dose distribution using a 3 mm/3% γ-test.
Geometrically, the beam-target rotational alignment difference was 0.3° ± 0.6° for fixed rotation and 0.3° ± 1.3° for active rotation. Dosimetrically, the average failure rate for the γ-test for a fixed rotated target was 11% with tracking and 36% without tracking. The average failure rate for an actively rotating target was 9% with tracking and 35% without tracking.
For the first time, real-time target rotation has been accurately detected and adapted to during radiation delivery via DMLC tracking. The beam-target rotational alignment difference was mostly within 1°. Dose distributions to fixed and actively rotating targets with DMLC tracking were significantly superior to those without tracking.
分别观察到肺肿瘤和前列腺肿瘤的分次内旋转超过 45°和 25°。目前的放疗并没有常规适应这种旋转,这可能会影响肿瘤的剂量覆盖。本研究旨在研究一种电磁引导的实时动态多叶准直器(DMLC)跟踪系统适应分次内肿瘤旋转的几何和剂量学性能。
材料/方法:目标旋转通过改变治疗床角度来提供。目标旋转由集成在配备实时 DMLC 跟踪系统的瓦里安直线加速器上的研究型 Calypso 系统测量。通过电子射野影像系统测量几何光束-靶旋转对准差异。通过二维电离室阵列量化剂量学准确性。对于每个射束,测试了以下五种输送模式:1)未旋转的靶(参考);2)固定旋转的靶,带有跟踪;3)固定旋转的靶,不带跟踪;4)主动旋转的靶,带有跟踪;5)主动旋转的靶,不带跟踪。使用 3 毫米/3%γ测试测量并比较了后四种模式的剂量学性能与参考剂量分布。
在几何上,固定旋转的光束-靶旋转对准差异为 0.3°±0.6°,主动旋转的为 0.3°±1.3°。在剂量学上,带跟踪的固定旋转靶的γ测试平均失败率为 11%,不带跟踪的为 36%。带跟踪的主动旋转靶的平均失败率为 9%,不带跟踪的为 35%。
首次通过 DMLC 跟踪在放射治疗中准确检测和适应实时目标旋转。光束-靶旋转对准差异主要在 1°以内。带 DMLC 跟踪的固定和主动旋转靶的剂量分布明显优于不带跟踪的。